PATENT CLAIM ANALYSIS

Application Number: 15748014
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "387000"]

Abstract:
The present invention relates to the adduct (2E)-but-2-enedioic acid-3-(2-{[4-(trifluoromethoxy)phenyl]amino}-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]-1H-benzimidazol-yl)propanoic acid (1:4), methods for preparing this adduct, pharmaceutical compositions comprising this adduct and also the use of this adduct for preparing a medicament for the treatment of a disease.

Claim (Index 11):
The method of  claim 4 , wherein the step of crystallizing out of (2E)-but-2-enedioic acid-3 -(2-{[4-(trifluoromethoxy)phenyl]amino}-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]-1H-benzimidazol-5-yl)propanoic acid (1:4) comprises concentrating the solution.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15118154', '15744641', '15520385', '15742363', '15520384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7607487956343563
- 35 USC 102 Novelty (BERT): 0.5216276285104253
- Combined Prediction Score: 0.7368366789219631
- Mean Citation Score: 285.973766
- Max Citation Score: 307.88104
- Similarity Product: 244.7664045487404

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test